DEXCOM INC — Director's Dealing 2014

Sep 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-09-12

Reporting Person: Balo Andrew K (SVP, Regulatory and Clinical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-12	Common Stock	D	4404.0	$43.3624	Disposed	150130	Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 83,959 unvested restricted stock units, 50,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 25,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 8,959 of which were granted on March 8, 2012 and shall vest through March 8, 2015.